FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia - File, T M, Jr; Low, D E; Eckburg, P B; FOCUS 1 investigators (J Antimicrob Chemother, 2011)